BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36412403)

  • 1. Cisplatin versus gemcitabine as concurrent chemoradiotherapy in squamous cell carcinoma cervix: A comparative study of clinical response and toxicities.
    Singh R; Singh Banipal RP; Goyal LD
    J Cancer Res Ther; 2022; 18(6):1518-1524. PubMed ID: 36412403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study.
    Wang CC; Chou HH; Yang LY; Lin H; Liou WS; Tseng CW; Liu FY; Liou JD; Huang KG; Huang HJ; Huang EY; Chen CH; Chang TC; Chang CJ; Hong JH; Lai CH
    Gynecol Oncol; 2015 Jun; 137(3):462-7. PubMed ID: 25827291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.
    Dueñas-González A; Zarbá JJ; Patel F; Alcedo JC; Beslija S; Casanova L; Pattaranutaporn P; Hameed S; Blair JM; Barraclough H; Orlando M
    J Clin Oncol; 2011 May; 29(13):1678-85. PubMed ID: 21444871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study.
    Dueñas-González A; Cetina-Perez L; Lopez-Graniel C; Gonzalez-Enciso A; Gómez-Gonzalez E; Rivera-Rubi L; Montalvo-Esquivel G; Muñoz-Gonzalez D; Robles-Flores J; Vazquez-Govea E; de La Garza J; Mohar A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):817-23. PubMed ID: 15708261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.
    Shrivastava S; Mahantshetty U; Engineer R; Chopra S; Hawaldar R; Hande V; Kerkar RA; Maheshwari A; Shylasree TS; Ghosh J; Bajpai J; Gurram L; Gulia S; Gupta S;
    JAMA Oncol; 2018 Apr; 4(4):506-513. PubMed ID: 29423520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial.
    Umanzor J; Aguiluz M; Pineda C; Andrade S; Erazo M; Flores C; Santillana S
    Gynecol Oncol; 2006 Jan; 100(1):70-5. PubMed ID: 16288803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
    Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial.
    da Costa SCS; Bonadio RC; Gabrielli FCG; Aranha AS; Dias Genta MLN; Miranda VC; de Freitas D; Abdo Filho E; Ferreira PAO; Machado KK; Scaranti M; Carvalho HA; Estevez-Diz MDP
    J Clin Oncol; 2019 Nov; 37(33):3124-3131. PubMed ID: 31449470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study.
    Cihoric N; Tsikkinis A; Vlaskou Badra E; Glatzer M; Novak U; Scherz A; Shelan M; Soldatovic I; Yojena CKK; Aebersold DM; Lössl K
    Radiat Oncol; 2017 Dec; 12(1):202. PubMed ID: 29273076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Chemotherapy be Integrated with Brachytherapy in Locally Advanced Carcinoma Cervix- A Proof of Principle Study.
    Gupta S; Giridhar P; Sharma D; K P H; P K J; Rath GK
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2653-2657. PubMed ID: 31554360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
    Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
    Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.
    Gandhi AK; Sharma DN; Rath GK; Julka PK; Subramani V; Sharma S; Manigandan D; Laviraj MA; Kumar S; Thulkar S
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):542-8. PubMed ID: 24074927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent Cisplatin-Based Chemoradiation in Squamous Cell Carcinoma of Cervix.
    Hashmi H; Maqbool A; Ahmed S; Ahmed A; Sheikh K; Ahmed A
    J Coll Physicians Surg Pak; 2016 Apr; 26(4):302-5. PubMed ID: 27097702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly cisplatin 20 mg/m2 in patients with carcinoma of cervix receiving pelvic radiotherapy at Srinagarind Hospital: a randomized controlled trial.
    Punushapai U; Yuenyao P; Chumworathayi B; Luanratanakorn S; Udomthavornsuk B
    Asian Pac J Cancer Prev; 2010; 11(1):201-7. PubMed ID: 20593957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase 3 trial comparing 2 cisplatin dose schedules in 326 patients with locally advanced squamous cell cervical carcinoma: long-term follow-up.
    Nagy VM; Ordeanu C; Coza O; Alin CR; Traila A; Todor N
    Int J Gynecol Cancer; 2012 Nov; 22(9):1538-44. PubMed ID: 23070071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer Patients with Comorbidities.
    Brau-Figueroa H; Arango-Bravo E; Castro-Eguiluz D; Galicia-Carmona T; Lugo-Alferez LA; Cruz-Bautista I; Jiménez-Lima R; Cetina-Pérez L
    Cancer Res Treat; 2022 Apr; 54(2):554-562. PubMed ID: 34384015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the progression free survival advantage of concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in patients with advanced cervical cancer worth the additional cost? A cost-effectiveness analysis.
    Smith B; Cohn DE; Clements A; Tierney BJ; Straughn JM
    Gynecol Oncol; 2013 Sep; 130(3):416-20. PubMed ID: 23718933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies.
    Duenas-Gonzalez A; Lopez-Graniel C; Gonzalez-Enciso A; Mohar A; Rivera L; Mota A; Guadarrama R; Chanona G; De La Garza J
    Ann Oncol; 2002 Aug; 13(8):1212-9. PubMed ID: 12181244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent Weekly versus Three Weekly Cisplatin with Radiotherapy in Locally Advanced Uterine Cervical Carcinoma.
    Hasan MR; Bari MA; Alam S; Sah GS
    JNMA J Nepal Med Assoc; 2018; 56(213):842-847. PubMed ID: 31065118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemoradiation with weekly gemcitabine and cisplatin for locally advanced cervical cancer.
    Hashemi FA; Akbari EH; Kalaghchi B; Esmati E
    Asian Pac J Cancer Prev; 2013; 14(9):5385-9. PubMed ID: 24175831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.